XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   112,407      
Beginning balance at Dec. 31, 2023 $ 436,874 $ 112 $ 2,405,043 $ (1,962,575) $ (5,706)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (20,621)     (20,621)  
Other comprehensive income (loss), net of tax (4,421)       (4,421)
Issuance of common stock under award and purchase plans, net (in shares)   1,422      
Issuance of common stock under award and purchase plans, net (2,710) $ 1 (2,711)    
Repurchase of common stock (in shares)   (2,409)      
Repurchase of common stock (30,049) $ (2)   (30,047)  
Excise tax on share repurchases (90)     (90)  
Stock-based compensation $ 13,877   13,877    
Issuance of common stock upon conversion of 2024 Notes (in shares) 4,578 4,578      
Issuance of common stock upon conversion of 2024 Notes $ (52) $ 5 (57)    
Ending balance (in shares) at Jun. 28, 2024   115,998      
Ending balance at Jun. 28, 2024 392,808 $ 116 2,416,152 (2,013,333) (10,127)
Beginning balance (in shares) at Mar. 29, 2024   111,946      
Beginning balance at Mar. 29, 2024 409,154 $ 112 2,410,094 (1,992,339) (8,713)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (12,532)     (12,532)  
Other comprehensive income (loss), net of tax (1,414)       (1,414)
Issuance of common stock under award and purchase plans, net (in shares)   225      
Issuance of common stock under award and purchase plans, net (839)   (839)    
Repurchase of common stock (in shares)   (751)      
Repurchase of common stock (8,373) $ (1)   (8,372)  
Excise tax on share repurchases (90)     (90)  
Stock-based compensation 6,954   6,954    
Issuance of common stock upon conversion of 2024 Notes (in shares)   4,578      
Issuance of common stock upon conversion of 2024 Notes (52) $ 5 (57)    
Ending balance (in shares) at Jun. 28, 2024   115,998      
Ending balance at Jun. 28, 2024 $ 392,808 $ 116 2,416,152 (2,013,333) (10,127)
Beginning balance (in shares) at Dec. 31, 2024 116,735 116,735      
Beginning balance at Dec. 31, 2024 $ 465,258 $ 117 2,432,733 (1,953,495) (14,097)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 8,811     8,811  
Other comprehensive income (loss), net of tax 7,133       7,133
Issuance of common stock under award and purchase plans, net (in shares)   1,743      
Issuance of common stock under award and purchase plans, net $ (150) $ 1 (151)    
Repurchase of common stock (in shares) (5,100) (5,089)      
Repurchase of common stock $ (50,102) $ (5)   (50,097)  
Excise tax on share repurchases (412)     (412)  
Stock-based compensation $ 15,864   15,864    
Issuance of common stock upon conversion of 2024 Notes (in shares) 0        
Ending balance (in shares) at Jun. 27, 2025 113,389 113,389      
Ending balance at Jun. 27, 2025 $ 446,402 $ 113 2,448,446 (1,995,193) (6,964)
Beginning balance (in shares) at Mar. 28, 2025   114,679      
Beginning balance at Mar. 28, 2025 446,130 $ 115 2,442,010 (1,983,872) (12,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 2,871     2,871  
Other comprehensive income (loss), net of tax 5,159       5,159
Issuance of common stock under award and purchase plans, net (in shares)   318      
Issuance of common stock under award and purchase plans, net (655)   (655)    
Repurchase of common stock (in shares)   (1,608)      
Repurchase of common stock (14,023) $ (2)   (14,021)  
Excise tax on share repurchases (171)     (171)  
Stock-based compensation $ 7,091   7,091    
Ending balance (in shares) at Jun. 27, 2025 113,389 113,389      
Ending balance at Jun. 27, 2025 $ 446,402 $ 113 $ 2,448,446 $ (1,995,193) $ (6,964)